A recent study published in Diabetes, Obesity and Metabolism shows that initiating an automated insulin delivery (AID) system improves glycemic control in children and adolescents with type 1 diabetes (T1D) who struggle to achieve optimal control with traditional methods. The study, led by Maaria Kiilavuori, MD, from the University of Helsinki, included 79 patients aged 7 to 16 years, all of whom had hemoglobin A1C levels greater than 53 mmol/mol (7%).

The findings revealed that after starting the AID system, participants experienced significant improvements in glycemic control. Between 0 to 3 months, time in tight range and time in range increased by an average of 11.7% and 18.1%, respectively. Hemoglobin A1c and mean sensor glucose levels also decreased significantly, and these positive effects were maintained over the 12- and 24-month follow-up periods. The researchers concluded that AID could be a viable treatment option for pediatric patients with T1D, particularly in those with difficulties in managing their diabetes effectively.

Reference: Solomon L. Automated Insulin Delivery System Improves Glycemic Control in Youth. HealthDay. Published December 12, 2024. Accessed January 20, 2025. https://www.healthday.com/healthpro-news/diabetes/automated-insulin-delivery-system-improves-glycemic-control-in-youth